Wolf-man jack
3 days ago
WQLF SAYS; Do YQU Remember
when CV Sciences first got into the Hemp Food business? Are we returning to the past? Have Mercy Have Faith Have Patience Have International Partners and M&A’s WQLF Ahooooooo
SNAAC CBD Launches Hemp CBD Sports Bar
This link below came out on August 19, 2023. The original announcement date was in September 5, 2018. Because of the legal environment at the time, the product became available for a short period of time .The SNAAK company is headquartered in California.
🌐
Naturalproductsinsider
naturalproductsinsider.com
CV Sciences ventures into food space following CBD safety assessment
August 19, 2023 - The launch marked CV Sciences' debut in the food
https://www.supplysidesj.com/supplement-regulations/cv-sciences-ventures-into-food-space-following-cbd-safety-assessment
SNAAC CBD Launches Hemp CBD Sports Bar
https://www.nosh.com/food-wire/2018/snaac-cbd-launches-hemp-cbd-sports-bar/
CV Sciences CBD Developments
“CV Sciences, a leading consumer wellness company specializing in hemp extracts, has ventured into the food space through a collaboration with SNAAK BAR. This partnership has resulted in the launch of SNAAC CBD, a hemp-based CBD sports bar product line.
Key Highlights
First hemp-based CBD sports bar: SNAAC CBD is the industry’s first sports bar formulated with hemp cannabidiol (CBD), designed to improve athletic and workout performance through advanced phytocannabinoid nutrition.
Collaboration with SNAAK BAR: SNAAK BAR, founded by Anke-Juliana Thiel and Leon Garcia in 2012, partnered with CV Sciences to develop a sports bar using CV Sciences’ industry-leading brand, PlusCBD Oil.
PlusCBD Oil: The flagship brand from CV Sciences, PlusCBD Oil is a high-quality hemp extract that is not psychoactive, making it suitable for athletes and individuals seeking relief from various health concerns.
Product features: SNAAC CBD sports bars contain 12 superfoods, including raw unfiltered honey, almonds, and coconut oil, which support athletic performance, recovery, and overall well-being.
Availability: SNAAC CBD sports bars are available nationwide across the US, sold in natural, healthy, and organic food stores as well as online at www.PlusCBDOil.com.
CV Sciences’ Commitment to Quality
CV Sciences is committed to developing and supplying the highest-quality hemp extracts, including CBD. Their products undergo rigorous testing processes in state-of-the-art laboratories to ensure potency, efficacy, and safety.
About CV Sciences
CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing, and selling plant-based CBD products (PlusCBD Oil) to a range of market sectors.”
”All inventory is currently sold out, but we are taking it to the next level with new and even better products that are in production! Contact us for a custom order in the meantime, so we can accommodate your SNAAK Bar needs!”
https://snaakbar.com/shop/
Wolf-man jack
3 days ago
Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Status Date: Nov. 26, 2024
Nov. 26, 2024 NOA E-MAILED - SOU REQUIRED FROM APPLICANT
https://tsdr.uspto.gov/#caseNumber=98388857&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Trademark Notice of Allowance
“A Notice of Allowance (NOA) is an official document issued by the United States Patent and Trademark Office (USPTO) or Canadian Intellectual Property Office (CIPO) indicating that a trademark application has passed the examination process and is one step closer to registration. This notification is typically sent to applicants who have filed intent-to-use (ITU) trademark applications.
Key Points:
Intent-to-Use (ITU) applications only: NOAs are issued for ITU applications, not for applications based on actual use of the mark in commerce.
Publication stage: The NOA is typically issued after the trademark application has been published in the Trademark Official Gazette without opposition or extension requests.
Allowance: The NOA indicates that the USPTO or CIPO has approved the application, but it does not mean the mark has been registered.
Statement of Use (SOU) requirement: Within six months from the NOA date, applicants must file a Statement of Use (SOU) demonstrating how they use the trademark in commerce. The SOU must include a specimen (e.g., product packaging, website screenshot).
Extension requests: If the applicant cannot submit the SOU within the six-month timeframe, they can file one or more extension requests, but there are limits on the total number of extensions and the timeframe for submission.
Abandonment: Failure to file a timely SOU or request an extension may result in the application being abandoned.
Differences between US and Canada:
While both countries issue NOAs, the steps required after receipt of the notice differ. In the US, applicants must file an SOU within six months, whereas in Canada, applicants have 18 months to file a Declaration of Use or Excusable Non-Use.
In summary: A Notice of Allowance is a critical milestone in the trademark application process, indicating that the mark has passed examination and is ready for the next steps. Applicants must file a Statement of Use or request extensions to demonstrate use of the mark in commerce and avoid abandonment.”
Intent to Use Trademark Basis
“An Intent-to-Use (ITU) trademark application is a type of trademark application filed with the United States Patent and Trademark Office (USPTO) before using a mark in commerce. This application allows a trademark applicant to reserve the trademark rights against potential competitors, even if they have not yet started using the mark.
Key Features:
Good Faith Intent: The applicant must demonstrate a good faith intention to use the mark in commerce in the future.
No Actual Use: The mark is not yet being used in commerce at the time of filing.
Future Use: The applicant intends to use the mark in commerce within a specified period, typically within six months of the mark’s approval for registration.
Extensions: If the applicant is unable to use the mark within the initial six-month period, they can file additional extensions of time, up to a maximum of three years.
Statement of Use: Once the mark is being used in commerce, the applicant must file a Statement of Use with the USPTO, providing evidence of use and a specimen showing how the mark is being used.
Benefits:
Priority: Filing an ITU application gives the applicant priority over others who may later file for the same mark.
Protection: The ITU application reserves the trademark rights, preventing others from registering the same or similar mark.
Flexibility: The applicant can delay actual use of the mark while still maintaining the rights to the mark.
Common Scenarios:
New Business: A startup files an ITU application before launching their business, ensuring they have priority over others who may later file for the same mark.
Expansion: A company planning to expand into new markets or products files an ITU application, reserving the trademark rights before actual use begins.
Rebranding: A company rebranding or changing its name files an ITU application, allowing them to maintain control over the new mark before actual use begins.
Important Considerations:
Filing Fees: ITU applications incur additional fees compared to actual use applications.
Evidence Requirements: The applicant must provide evidence of intent to use the mark in commerce, including a sworn statement and, later, a specimen showing actual use.
Abandonment: If the applicant fails to file a Statement of Use or demonstrate actual use within the specified period, the ITU application may be abandoned, potentially losing the reserved rights.
In summary, an Intent-to-Use trademark application is a strategic filing option for businesses or individuals planning to use a mark in commerce in the future. It allows them to reserve the trademark rights, prioritize their mark, and maintain flexibility while preparing for actual use. However, it’s essential to understand the associated fees, evidence requirements, and potential risks of abandonment.“
Trademark Statement of Use
“A Statement of Use (SOU) is a crucial filing with the United States Patent and Trademark Office (USPTO) that demonstrates a trademark’s use in commerce. It’s the final step in the trademark application process for certain applications. Here’s a breakdown of the key aspects:
Purpose: A SOU confirms that a trademark is being used in commerce for the specific goods or services listed in the original application. It ensures that the mark is being used in the ordinary course of trade, as intended.
Requirements: To file a SOU, you must have:
Notice of Allowance (NOA): Receive a NOA from the USPTO, indicating that your trademark application has been approved for registration.
Verification of Use: Submit a sworn statement confirming that the trademark is currently in use in commerce for the specified goods or services.
Specimens of Use: Provide specimens that demonstrate the mark’s actual use, such as labels, tags, packaging, brochures, advertising materials, or other relevant examples.
Filing Fee: There is a fee associated with filing a SOU, which varies depending on the type of application and the number of classes of goods or services.
Timing: The SOU must be filed within a specific time frame after the initial NOA is issued, typically six months. If you’re unable to meet this deadline, you can file a Request for Extension of Time to File a Statement of Use.
Not all trademark applications require a SOU: If your application is based on actual use of the mark in commerce from the beginning, you won’t need to file a SOU. Instead, you would submit evidence of use with your initial application.
Best Practices: To ensure a successful SOU filing, it’s recommended to:
Consult with a trademark attorney for guidance.
Review the USPTO’s official guidelines and resources.
Ensure that your specimens accurately demonstrate the mark’s use in commerce.
File the SOU within the allotted time frame to avoid potential delays or rejections.
By understanding the Statement of Use trademark process, you can successfully complete the final step in registering your trademark and protect your brand’s intellectual property.”
Wolf-man jack
3 days ago
WQLF SAYS:
Item 8.01 Other Events
“As previously disclosed by CV Sciences, Inc. (the “Company”), on November 5, 2021, Michael J. Mona Jr. (“Mona”) filed a complaint against the Company for breach of contract and negligence in Nevada state court seeking to recover from the Company the amount of federal and state taxes, interest and penalties owed by Mona for taxes on income received by him upon the vesting and settlement of restricted stock units in 2019. On November 3, 2022, the court ordered the case into arbitration. On December 6, 2022, Mona filed a demand for arbitration against the Company and certain of its officers with the American Arbitration Association (the “AAA”). The hearing on the merits in the case began with AAA on April 8, 2024, and the arbitrator heard five days of testimony. The hearing resumed on May 21, 2024 and concluded on May 23, 2024.
On November 20, 2024, the Company received the final arbitration award from the AAA finding against Mona on all claims for relief and in favor of the Company and management and holding that Mona shall take nothing from the arbitration. “
https://www.sec.gov/cgi-bin/browse-edgar?company=Cv+sciences+&owner=exclude&action=getcompany
Wolfman Jack Said: Let The Midnight Special Shine It’s Ever Light On Me Amen and Amen 🙏 Have Mercy Ahooooooo
Wolf-man jack
3 days ago
WQLF SAYS;
Elevated Softgels by CV Sciences
“CV Sciences, Inc., a consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, acquired Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry, in May 2024.
Key Highlights:
Operational Flexibility: Elevated Softgels offers low to large minimum order quantity (MOQ) production runs, enabling efficient use of capital and rapid product development.
GMP-Certified and FDA-Registered: The manufacturing facility is certified by Good Manufacturing Practices (GMP) and registered with the US Food and Drug Administration (FDA), ensuring high-quality products.
Scalability: The acquisition enables CV Sciences to increase production capacity, leveraging Elevated Softgels’ ability to manufacture millions of softgels per day.
Cost Savings: CV Sciences plans to in-source the manufacturing of select +PlusCBD branded products, resulting in meaningful cost savings.
Synergies: The acquisition is expected to drive long-term growth and shareholder value by leveraging CV Sciences’ relationships with other hemp and supplement companies.
Product Offerings:
Elevated Softgels manufactures a range of products, including:
CBD Softgel Capsules: Reserve Collection Softgels featuring 25 mg of CBD, terpenes, minor cannabinoids, fatty acids, and 2.5 mg of THC per daily recommended serving.
Custom Softgels: Clients can create their own custom softgels with various strengths, carrier oils (organic or conventional), and MCT or hemp seed oil options.
Tinctures: Stock formulas and custom options available, with the ability to change flavors at 100 units and bottle designs at 360 units.
Manufacturing Capabilities:
Elevated Softgels’ large-scale softgel manufacturing setup allows for:
High-Volume Production: Over 100,000 softgels per hour or millions per day.
Bulk or Bottled Options: Clients can purchase products in bulk or bottled units, with stock components kept in-house for rapid fulfillment.
Conclusion:
The acquisition of Elevated Softgels by CV Sciences enhances the company’s product offerings, manufacturing capabilities, and scalability, positioning it for long-term growth and success in the consumer wellness industry.”
Wolf-man jack
4 days ago
🇦🇺 WQLF SAYS;Australia Rocks 🇦🇺
Extract Labs Inc. Due Diligence
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175431796
WQLF SAYS: What do these FOUR companies have to do with Australia and Melbourne, Australia in particular? Have Mercy Have Faith Have Patience Have International Partners and M&A’s WQLF Ahooooooo
Global Nicotine Replacement Therapy Market – Industry Trends and Forecast to 2029
Pharmaceutical Upcoming Report May 2022
Global Nicotine Replacement Therapy Market, By Product Type (Patches, Gums, Logenzes, Inhalers, Nasal Spray, Sublingual Tablets)
https://www.databridgemarketresearch.com/reports/global-nicotine-replacement-therapy-market
SLEUTH SAID;
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174675975
🇦🇺 Melbourne, Australia 🇦🇺 https://www.ingenucro.com/
🇦🇺 Melbourne, Australia 🇦🇺
https://www.incannex.com/
https://api-dev.kscope.io/ks-doc-view?key=c81d766a-c124-11ed-9981-0ed29589fc89&content=benznews&docid=5ebc9f217a3a57b0f9e65164e7f3ec7b81f6e24c
🇦🇺 Extract Labs Australia 🇦🇺
“Based on the provided search results, here’s what I found:
Australian Presence: Extract Labs is a hemp extraction company located in Boulder, Colorado, USA. However, they have a presence in Australia, as evidenced by their involvement in the Australian cannabis market and their mention of Australian customers.
cGMP Certified Facilities: Extract Labs’ facilities are cGMP (current Good Manufacturing Practice) certified, ensuring a clean and safe environment for production. This standard is set by the Food and Drug Administration (FDA).
Batch Number and Lab Reports: All Extract Labs’ CBD products come with a batch number, which can be input into their Batch Database to access lab reports for download. This demonstrates their commitment to transparency and quality control.
Australian CBD Products: Extract Labs offers CBD products for the Australian market, including full-spectrum, broad-spectrum, and CBD isolate options, as well as flavored tinctures. They are a reputable brand founded by military veteran Craig Henderson, using local, organic hemp for their products.
Key Takeaways:
Extract Labs has a presence in Australia, catering to local customers.
Their facilities are cGMP certified, ensuring high-quality production.
Products come with batch numbers and lab reports available for download.
They offer a range of CBD products for the Australian market.
Please note that Extract Labs is a US-based company, and their products may not be available for direct purchase in Australia due to local regulations. However, they may have authorized distributors or online retailers that ship to Australia. It’s essential to verify the availability and legality of their products in your region before making a purchase.“
🇦🇺 CV Sciences Patents in Australia 🇦🇺
“Based on the provided search results, here’s a summary of CV Sciences’ patents in Australia:
Patentability of Genetic Material in Australia: CV Sciences’ patents in Australia focus on the patentability of genetic material, particularly in the context of life sciences research. The Australian Patent Office (APO) has granted patents for isolated bacteria, cell lines, hybridomas, and genetically manipulated organisms.
Gene Sequences: The APO has also granted patents with claims defining gene sequences, such as those related to erythropoietin. The patentability of gene sequences in Australia is discussed in the context of the Kirin-Amgen Inc v. Board of Regents of University of Washington and Genetics Institute, Inc. (1995) case.
Patent Allowance for CBD and Nicotine Formulation: CV Sciences received a Notice of Allowance from the Australian Patent Office (IP Australia) for a patent application (15/426,617) covering methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing cannabidiol (CBD) and nicotine.
Some key points to note:
Australia has a generous patent system, granting patents for advances in life sciences research, including those involving naturally occurring genetic material.
The APO has a long history of granting patents for isolated bacteria, cell lines, hybridomas, and genetically manipulated organisms.
Gene sequences are patentable in Australia, but the patentability of naturally occurring genetic material is subject to debate and has been discussed in court cases.
It’s essential to consult the original patent documents and relevant court decisions for a comprehensive understanding of CV Sciences’ patents in Australia. The provided search results are summarized and condensed for clarity, but they may not include all the details and nuances of the original sources.“
Wolfman Jack Said: Who Can It Be Now? Men At Work From Down Under You Now Understand You Understand Have Mercy Ahooooooo
Wolf-man jack
5 days ago
WQLF SAYS: As the WQLF mentioned in an earlier post that it appears JD is not limited to JUST CBD. The Freudian slip is around the 8:00 minute mark on this interview. The whole interview gives us insight to the Back To The Future Market Plan for CV Sciences YQU Understand. Is MJ market just around the CORNER? Have Mercy Have Faith Have Patience Have International MJ and CBD Partners and M&A’s WEREWQLF of 🍁 YQU NOW Understand YQU Understand Ahooooooo
Planted – Joseph Dowling
Sara sits down with Joseph Dowling, CEO of CV Sciences. [Ep99]
https://radiomisfits.com/psp99/
Wolfman Jack Said; Radio Misfits from FM 99 WNOR Norfolk, Virginia
Tommy and the Bull FM 99
“Tommy and the Bull is a popular morning radio show broadcast on FM99 in Virginia, specifically in Hampton Roads. The show, hosted by Tommy Griffiths and Rick Rumble, began in 1995 and has been the most popular morning radio show in Virginia since then.
Show Format
“The show features comedic banter between Tommy and Rumble, as well as their co-workers, and includes various radio bits, pranks, and interviews. They take calls from listeners, read emails and text messages, and introduce segments such as “Stupid News” (daily at 6:45 AM and 8:45 AM), which features real-life news stories that seem absurd or illogical.
Radio Bits and Characters
Tommy and Rumble have created numerous fictional personalities, often portrayed by the hosts themselves, including:
Alex & Enrique (an eccentric gay couple)
Skip Giblet (a self-help guru and motivational speaker)
Roy Forehead (someone with many issues)
Cliff Andrews (Assistant Public Service Director at FM99)
They also play bits created by other artists and conduct formal interviews with celebrities, politicians, authors, and ordinary citizens involved in news stories. Fake celebrity phone interviews are also a staple of the show.
History
The FM99 morning show originated in the 1980s as “Reeger & the Bull” with Ron Reeger and Henry Del Toro (aka “The Bull”). When Reeger left, Jimmy Ray Dunn took over, and the show became “Jimmy & the Bull” until Dunn’s departure in 1990. From 1990 to 1995, the show was called “Tommy & the Bull” with Tommy Griffiths and Del Toro.
Notable Guests
The show has featured various comedians, including Tommy Davidson, Jim Florentine, Ralphie May, Aries Spears, Harland Williams, John Witherspoon, and J. Medicine Hat (now deceased).
Availability
Tommy and the Bull FM99 airs weekdays from 5:30 AM to 10:00 AM (sometimes starting and ending a few minutes late) on FM99 in Virginia. You can also tune in online or listen to past episodes on-demand.“
Wolf-man jack
5 days ago
WQLF SAYS; The WQLFPACK believes that Craig decided to merge with CV Sciences instead of going Public. He will own at least 10 percent of the CVSI ($1,000,000 in value at $.04/.045/.05 cents per share) stock and will increase it by another amount once Extract meets the maximum of $600,000 in shares Broken up in two tranches in a two year period. $300,000 each year. This acquisition/merger is amazing and WE can’t wait for the next PR Acquisition coming soon WE understand YQU Understand. Have Mercy Have Faith Have Patience Have International Partners and M&A’s WQLF Ahooooooo
Look for Maxim Group to get us the Monies to get us through 2025 before profitability comes to fruition.The loan from last year will be paid off in July 2025 or Sooner with a $70,000 refund.
Extract Labs Hemp Sourcing
“Based on the provided search results, Extract Labs sources its hemp from American-grown hemp, specifically mentioning that they “start by sourcing quality American-grown hemp” and that their hemp products are “made in Boulder, CO” and “shipped worldwide from Lafayette, Colorado USA”. There is no mention of specific farms or suppliers, but it appears that Extract Labs prioritizes domestic hemp sourcing.
Additionally, the company’s commitment to transparency and quality control is emphasized, with claims of “keeping every step of production in-house” and “vertically integrated” operations. This suggests that Extract Labs may have a direct relationship with hemp farmers or processors, allowing for greater control over the quality and origin of their hemp.
It’s worth noting that Extract Labs’ focus on minor cannabinoids, such as CBG, CBT, and CBN, may require sourcing hemp with specific terpene profiles or cannabinoid concentrations. The company’s expertise in extraction and processing may enable them to work with a variety of hemp suppliers to meet their product requirements.
In summary, while the exact hemp suppliers are not disclosed, Extract Labs sources its hemp from American-grown hemp, prioritizing quality and control through its vertically integrated operations.“
https://extractlabshemp.com/
What is HHC and What Does it Do?
https://www.extractlabs.com/press/what-is-hhc-and-what-does-it-do/
Extract Labs
“Owning and operating every aspect of the manufacturing process from plant to product sets us apart from other CBD companies. We’re not only a brand, we’re also a full scale processor of hemp products shipping worldwide from Lafayette Colorado USA.“
https://www.extractlabs.com/tag/hhc/
Where can I find HHC products?
Extract Labs offers two HHC vape products in its lineup. With high-quality, lab-tested ingredients, each vape offers a custom blend of minor cannabinoids that has been optimized for effect of our in-house experts.
🌐
extractlabs.com
extractlabs.com
HHC Explained: Understanding What HHC Is, Benefits, and More
Extract Labs HHC PRODUCTS
https://wholesale.extractlabs.com/store/hhc-products/
HHC (Hexahydrocannabinol): Uses, Side Effects, and More
Medically Reviewed
https://www.webmd.com/mental-health/addiction/what-is-hhc
SHOP BY CANNABINOID
https://www.extractlabs.com/store/cannabinoids/
Wolf-man jack
5 days ago
TOMMY @ Yahoooooo Said:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175424981
WQLF SAYS: Before the Acquisition announcement, the WQLF was hoping there was a way for CV Sciences to get the hades out of WOKE California. It appears that the WQLF’s premonition may come to fruition. The Lease for the San Diego office space will be most likely vacated at the end of May 2025 according to the lease agreement that can be found in the SEC filings on page 12.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1510964/000095017024127040/cvsi-20240930.htm
5. LEASES
In April 2022, the Company entered into a new lease agreement for its main office facility. The lease is for the Company's operations, warehouse, sales, marketing and back office functions. The facility is approximately 6,000 square feet and located in San Diego, California. The lease term is three years with a total lease obligation of approximately $0.4 million. The lease does not include an option to renew. Based on the present value of the lease payments for the remaining lease term, the Company recognized an operating lease asset of $0.3 million and lease liabilities for operating leases of $0.4 million, respectively, on May 1, 2022. As of September 30, 2024, the Company had an operating lease obligation and operating lease asset of $0.1 million related to the facility.
The Company's operating leases are included in "Right of use assets" on the Company's September 30, 2024 Condensed Consolidated Balance Sheet, and represents the Company's right to use the underlying assets for the lease term. The Company's obligation to make lease payments is included in "Operating lease liability - current" and "Operating lease liability" on the Company's September 30, 2024 Condensed Consolidated Balance Sheet. Operating lease expense is recognized on a straight-line basis over the lease term. During the three and nine months ended September 30, 2024, the Company's total lease cost was $29,357 and $86,380, respectively. Total lease costs was mostly comprised of operating lease costs. Short-term lease costs related to short-term operating leases and variable lease costs were $35,657 and $59,429 during the three and nine months ended September 30, 2024.
Because the rate implicit in the leases is not readily determinable, the Company uses the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. Information related to the Company's operating lease assets and related lease liabilities were as follows:
September 30, 2024
Remaining lease term (in months)
8
Discount rate
7.0%
Maturities of lease liabilities as of September 30, 2024 were as follows (in thousands):
Year ending December 31,
2024 (remaining three months)
$35
2025
$.59
Total lease liabilities
$92
Current operating lease liabilities $92
Non-current operating lease liabilities
Total lease liabilities
$92
One of the benefits from the Acquisition and the possibility of moving CV Sciences headquarters to Boulder Colorado is the HIGH TAXES and Ridiculous Regulations in California. Here is the difference of Corporate Taxes between California and Colorado.
Colorado vs California Corporate Tax
Based on the provided information, here’s a summary of the key differences between Colorado’s corporate tax and California’s corporate tax:
Tax Rate:
Colorado: Flat 4.55% assessed on Colorado net income (defined as federal taxable income with modifications)
California: Graduated tax rate, ranging from 8.84% to 13.3% based on net income (as of 2021)
Net Income Definition:
Colorado: Uses federal taxable income with modifications
California: Uses federal taxable income with modifications, but with some additional adjustments (e.g., net operating losses, tax credits)
Carryforward Period:
Colorado: 20-year carryforward period for net operating losses (as of 2021)
California: 3-year carryforward period for net operating losses (as of 2021)
Other Considerations:
Both states have a flat tax rate for corporations, but California’s rate is more complex due to its graduated structure.
Colorado’s 4.55% rate is relatively low compared to other states, while California’s rates vary widely depending on net income.
Colorado has a simpler tax code and fewer tax credits and deductions compared to California.
Rankings:
According to the 2024 State Business Tax Climate Index, Colorado ranks 27th, while California ranks 48th (out of 50 states).
In summary, Colorado’s corporate tax system is characterized by a flat 4.55% rate, a simpler code, and a longer carryforward period for net operating losses. California’s system, on the other hand, has a more complex graduated rate structure, with rates ranging from 8.84% to 13.3%. While both states have their own strengths and weaknesses, Colorado’s tax environment is generally considered more business-friendly and competitive compared to California’s“
It appears that Cv Science’s will be locating our Headquarters to Boulder, Colorado. In the acquisition agreement, the building of Extract Labs Inc. is owned by CEO Craig Henderson’s LLC company. The agreement states that he is to extend the lease for an additional three years. CV Sciences will be extracting at the facilities utilizing their Extraction equipment. We will also be extracting some of our products at Elevated Softgels located in Grand Junction, Colorado located 255 miles from Boulder Colorado. The hemp supplies currently utilized by Extract Labs and CV Sciences is grown in Colorado which in return will produce cost savings to CV Sciences and Extract Labs. With the combination of both concerns, buying in a larger bulk will also produce a higher cost savings. This is how Scalability works.
"We are thrilled that Extract Labs and its employees are joining CV Sciences as another milestone in our transition to a thriving health and wellness company. The acquisition synergies are expected to increase our revenue and customer base, allow us to leverage our key assets, optimize operations and processes, and drive long-term growth and shareholder value. Extract Labs is a stand-alone profitable business and our plan is to increase its existing revenue base and further leverage its existing capacity," said Joseph Dowling, Chief Executive Officer of CV Sciences. "In addition, we are planning to in-source the manufacturing of select +PlusCBD™ branded products providing an opportunity for meaningful cost savings. Extract Labs manufacturing capability will provide us with greater control over our supply chain and accelerate our new product development cycle."
https://www.morningstar.com/news/pr-newswire/20241121ny63880/cv-sciences-inc-enters-into-definitive-agreement-to-acquire-extract-labs
https://elevatedsoftgels.com/
Stores Carrying Extract Labs CBD
“Based on the provided search results, Extract Labs CBD products are available for wholesale and retail purchase through their official website and physical store in Lafayette, Colorado. Additionally, they have a wholesale portal for authorized retailers to purchase their products. Here are some details:
Extract Labs Official Website: Customers can purchase Extract Labs CBD products directly from their website, including their full spectrum CBD oil, CBD creams, gummies, capsules, and more.
Physical Store: Extract Labs has a physical store located in Lafayette, Colorado, where customers can visit and purchase products in person.
Wholesale Portal: Authorized retailers can sign up for the wholesale portal to purchase Extract Labs CBD products at discounted rates for resale in their own stores or online platforms.
Authorized Retailers: Although specific retailers carrying Extract Labs CBD products are not listed, the company mentions that their products are available through various online marketplaces and brick-and-mortar stores. Customers can contact Extract Labs directly to inquire about authorized retailers in their area.
Please note that the search results do not provide an exhaustive list of specific stores that carry Extract Labs CBD products. It’s recommended to visit the Extract Labs website or contact their customer service to find authorized retailers or to inquire about purchasing products directly from the company.”
Wolf-man jack
5 days ago
WQLF SAYS:
Trump Appoints Dr. Janette Nesheiwat, Former COVID Vaccine Advocate Turned Critic, as Surgeon General
By Jim H?ft Nov. 23, 2024 9:15 am
https://www.thegatewaypundit.com/2024/11/trump-appoints-dr-janette-nesheiwat-former-covid-vaccine/
Dr. Janette Nesheiwat Profile
“Dr. Janette Nesheiwat, a renowned physician and Fox News medical contributor, has ventured into the world of CBD products. She is the creator of BC Boost, a line of CBD supplements that aim to boost immunity and overall well-being.
Background
https://bcboost.com/
As a board-certified medical doctor, Dr. Nesheiwat has a strong foundation in family and emergency medicine. Her experience as a medical news correspondent and TV host has given her a platform to share her expertise with a wide audience. Her passion for preventive medicine and public health led her to develop BC Boost, a natural supplement line that combines CBD with other wholesome ingredients.
BC Boost
According to Dr. Nesheiwat, BC Boost was inspired by her repeated advice to patients to take vitamin B12 and C to boost their immune systems. She found herself sharing this regimen with patients over and over, and thus, BC Boost was born. The supplement line is designed to provide a natural boost to the immune system, with a focus on using only the highest-quality ingredients.
Key Takeaways
Dr. Janette Nesheiwat is the creator of BC Boost, a CBD supplement line aimed at boosting immunity and overall well-being.
BC Boost combines CBD with other natural ingredients, such as vitamins B12 and C.
Dr. Nesheiwat’s experience as a medical news correspondent and TV host has given her a platform to share her expertise and promote her supplement line.
As a physician, Dr. Nesheiwat emphasizes the importance of using only natural, wholesome ingredients in her supplement line, reserving prescription medication for only when necessary.“
Wolf-man jack
7 days ago
🇦🇺 WQLF SAYS- Extract Labs 🇦🇺
4 Best CBD Oils in Australia
Best Formulas: Extract Labs CBD Tincture | full review
https://cbdthinker.com/best-cbd-oil-australia/
https://www.extractlabs.com/press/australian-cannabis/
Based on the provided search results, here’s what I found about Extract Labs Australia:
Location: Extract Labs is a Boulder, Colorado-based company, but they ship to Australia. They have a postal address in Lafayette, Colorado (1399 Horizon Ave, 80026).
Contact: You can reach out to them through their email (support[[ @harjee).
Price Range: Their products fall under the $$$ category, indicating a mid-range to premium pricing.
Distance: The distance from Lafayette, CO to Australia is approximately 1555.93 miles (2,497.93 km).
Verified Discounts: Extract Labs offers verified promo codes and coupons for discounts on their products. These codes are available for a limited time and can be used for sitewide, specific products, or categories.
Supercritical CO2 Extraction Equipment: Extract Labs provides on-site workforce training and manufacturing line commissioning services for their supercritical CO2 extraction equipment. They also offer custom-engineered extraction labs for hemp manufacturing, suitable for small producers to large-scale operations.
CBD Products: Extract Labs offers full-spectrum CBD oils, CBD gummies, and other products. They use local, organic hemp and provide third-party testing reports for their products.
Australian Market: Extract Labs has been featured in an article about the Australian cannabis market, highlighting their commitment to perfection and transparency. They have a Batch Database where customers can input batch numbers to access lab reports for their products.
Overall, Extract Labs is a reputable company that offers high-quality CBD products and extraction equipment, with a focus on transparency and customer satisfaction. They ship to Australia and provide verified discounts and third-party testing reports.“
Wolf-man jack
7 days ago
🇵🇱 WQLF SAYS: Extract Labs Acquisition 🇵🇱
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175423014
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175423093
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175423371
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175424530
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175424571
Delta 8 Legality in Poland
“Based on the provided search results, here is a summary of the legal status of Delta 8 in Poland:
According to the Regulation of the Minister of Health of 17 August 2018 on the list of psychotropic substances, narcotic drugs and new psychoactive substances, hemp herb other than fibre, containing more than 0.20% of the sum of delta-9-Tetrahydrocannabinol (THC) and Tetrahydrocannabinoleic acid (delta-9-THC-carboxylic acid) is not authorised in Poland.
Delta 8 THC (tetrahydrocannabinol) is a cannabinoid derived from the hemp plant, and its legal status in Poland is unclear.
Some online sources claim that Delta 8 products, including edibles, are available for purchase in Poland legally, citing the 2018 American Farm Bill as the basis for their legality. However, this claim is not supported by official Polish government sources or regulations.
There is no explicit mention of Delta 8 THC in the Act of 29 July 2005 on Counteracting Drug Addiction or the Regulation of the Minister of Health of 17 August 2018, which govern psychotropic substances in Poland.
In summary, based on the available information, it appears that Delta 8 THC is not explicitly legal or illegal in Poland. Its legal status is uncertain and may depend on the specific product and circumstances.
Recommendation: Due to the unclear legal status of Delta 8 THC in Poland, it is recommended to exercise caution and avoid purchasing or consuming Delta 8 products in Poland until further clarification or regulation is provided by the Polish government.“
https://www.hempiregardens.com/blogs/hempire-gardens-blog/delta-8-buy-delta-8-edibles-in-poland
https://www.hempiregardens.com/blogs/hempire-gardens-blog/delta-8-where-can-i-buy-delta-8-hash-in-poland
https://hemptoday.net/political-will-led-to-new-hemp-rules-that-will-help-polish-producers/
CVSI 007
Patentability
“It is generally possible to patent a cannabis-based product in Poland. The legislation concerning industrial property does not contain any specific restrictions in this respect. However, patents are generally not granted for inventions the exploitation of which would be contrary to public order or decency. Having said that, the exploitation of an invention is not regarded as contrary to public order only because it is prohibited by law.”
https://cms.law/en/int/expert-guides/cms-expert-guide-to-a-legal-roadmap-to-cannabis/poland
https://www.missionc.com/blogs/news/what-is-delta-8-thc
Wolf-man jack
7 days ago
WQLF SAYS ; ™️ ®️
Extract Labs Inc.
https://tsdr.uspto.gov/#caseNumber=97767163&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
https://tsdr.uspto.gov/#caseNumber=97773227&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
https://www.fox32chicago.com/video/1027126
https://www.extractlabs.com/cbd-industry/california-thc-ban-in-hemp/
https://www.healthline.com/health/extract-labs-review
https://www.extractlabs.com/
Extract Labs UK
Extract Labs UK Information
Based on the search results, Extract Labs is a US-based CBD company founded by combat veteran Craig Henderson, aiming to help fellow veterans suffering from PTSD and injuries. Although headquartered in the US, they have a presence in the UK and supply high-quality CBD products to the British market.
Key Features
Full-spectrum CBD products: Extract Labs offers full-spectrum CBD products, which include a small but legal amount of THC, allowing customers to benefit from the “entourage effect.”
High-quality products: Their products are made in-house in the US and have lab results available, ensuring transparency and quality.
Customer service: Customers praise the company’s responsive customer service, with some reviews mentioning personalized responses from team members.
UK-based distribution: Extract Labs has a UK-based distribution network, ensuring fast and reliable shipping to customers in the region.
Unbeatable prices and quality: According to their website, they offer unbeatable prices and quality, making them a competitive option in the UK CBD market.
Product Range
Extract Labs offers a variety of CBD products, including:
Oils
Creams
Concentrates
Edibles
Terpenes
Reviews and Ratings
Based on reviews from customers in the UK, Extract Labs has a strong reputation for quality products and excellent customer service. Some reviewers have mentioned the company’s commitment to transparency, with lab results available for all products.
Conclusion
Extract Labs is a reputable CBD company with a strong presence in the UK market. Their focus on quality, transparency, and customer service sets them apart from competitors. If you’re looking for high-quality full-spectrum CBD products in the UK, Extract Labs is definitely worth considering.“
HEMPELF. COM
“Our goal is to deliver happiness with excellent service and quality CBD products. But don’t take our word for it, see what over 4,400 satisfied customers have to say about UK’s number one CBD supplier. Read some HempElf reviews yourself if you don't take our word for it!”
https://hempelf.com/collections/extract-labs
Wolfman Jack Said: You are Bloody Well Right You Understand. Have Mercy Ahooooooo
Wolf-man jack
1 week ago
CRAIG SAYS; Ahoooooooooo
https://www.sec.gov/ix?doc=/Archives/edgar/data/1510964/000095017024129750/cvsi-20241115.htm
Item 1.01 Entry into a Material Definitive Agreement
On November 15, 2024, CV Sciences, Inc. (the “Company”) entered into a definitive Stock Purchase Agreement (the “Purchase Agreement”) by and among the Company, Extract Labs, Inc., a Colorado corporation (“Extract Labs”), Craig Henderson (“Henderson”), and Higher Love Wellness Company, LLC (“HLWC” and together with Henderson, the “Sellers”), pursuant to which the Company will purchase all of the outstanding shares of Extract Labs from the Sellers (the “Acquisition”). Extract Labs is a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals, and tinctures. The Acquisition is anticipated to close during the first quarter of 2025. Closing of the transaction is subject to customary conditions.
In consideration for the Acquisition, at closing, the Company (i) will make a cash payment of $400,000 to the Sellers, less a $20,000 holdback (the “Holdback Amount”), less certain assumed indebtedness and less certain transaction expenses, subject to certain other adjustments provided for in the Purchase Agreement (the “Closing Payment”), and (ii) will issue to the Sellers a number of shares of the Company's common stock with an aggregate value equal to $1,000,000 less certain assumed indebtedness, based on the trailing 60 day volume weighted average price (“VWAP”) of such common stock as of the trading day prior to the closing date (the “Closing Shares”) . The Closing Payment will be subject to adjustment, upward or downward, to the extent Extract Labs’ net working capital as of the closing is greater than or less than $880,000. Additionally, the Company shall be entitled to recover from the Sellers an amount equal to the unpaid balance of all accounts receivable that were included in the Extract Labs final working capital statement, to the extent they remain uncollected 90 days after the determination of the final working capital statement.
In addition to the consideration payable at closing, and as further consideration for the Acquisition, the Sellers shall be entitled to receive up to two additional earnout payments payable in shares of restricted common stock of the Company (the “Earnout Amount”). The Earnout Amounts shall be based on Extract Labs’ Net Revenue (as defined in the Purchase Agreement) generated during the 12-month period following the closing date (for the first calculation period) or 24-month period following the closing date (for the second calculation period) and will be calculated as follows:
•
If Extract Labs’ Net Revenue is at least $4,600,000 in the relevant calculation period, then the Earnout Amount for such period will be $300,000.
•
If Extract Labs’ Net Revenue is at least $4,300,000 but less than $4,600,000 in the relevant calculation period, then the Earnout Amount for such period will be $200,000.
•
If Extract Labs’ Net Revenue is at least $4,000,000 but less than $4,300,000 in the relevant calculation period, then the Earnout Amount for such period will be $100,000.
•
If Extract Labs’ Net Revenue is at least $3,500,000 but less than $4,000,000 in the relevant calculation period, then the Earnout Amount for such period will be $50,000.
•
If Extract Labs’ Net Revenue is less than $3,500,000 in the relevant calculation period, then the Earnout Amount for such period will be $0.
The shares issuable for each earnout payment, if any, shall be issued within 10 business days after the final determination of Extract Labs’ Net Revenue for each 12-month period following the closing date, as determined in accordance with the Purchase Agreement. The number of restricted shares of common stock of the Company issuable for each earnout payment, shall be determined based upon the thirty-day VWAP of the Company's common stock as of the 12-month anniversary of the closing date (for the first calculation period) or 24-month anniversary of the closing date (for the second calculation period).
The Sellers agreed that they will not, on any single trading day sell, transfer or otherwise dispose of any shares of Company common stock, including the shares issuable at closing, in an aggregate amount exceeding the greater of (i) 15% of the of the Company’s common stock sold in the aggregate based on the greater of the current or proceeding trading day, and (ii) $3,000 in gross value.
Subject to certain limitations, the Sellers and the Company have agreed to indemnify each other for losses arising from certain breaches of the Purchase Agreement and certain other liabilities.
The Purchase Agreement contains customary termination rights for each of Extract Labs and the Company, including the right to terminate if the transactions contemplated by the Purchase Agreement have not been completed by January
1
15, 2025. In the Purchase Agreement, Extract Labs and the Company have made customary representations and warranties and have agreed to customary covenants relating to the Acquisition. From the date of the Purchase Agreement until the closing, Extract Labs is required to conduct its business in the ordinary course of business consistent with past practices and to comply with certain covenants regarding the operation of its business.
Additionally, for a period of up to three years following the closing date, Henderson shall be prohibited from engaging in certain competitive and/or solicitation activities within the United States, as more particularly set forth in the Purchase Agreement.
Extract Labs leases an approximately 28,450 square foot building (the “Building”) from 1399 Horizon LLC (“Horizon”), which is wholly-owned by Henderson. Extract Labs is the guarantor of approximately $4 million of indebtedness of Horizon that is secured by a deed of trust on the Building (the “Loan”). At the closing of the Acquisition, Extract Labs will enter into a new 3-year lease (with the option to extend for up to three years) with Horizon. Following the closing of the Acquisition, Henderson and Horizon will jointly and severally indemnify Extract Labs against liability under its guarantee of the Loan, and Henderson will pledge his membership interest in Horizon to Extract Labs as security for such indemnification obligations and Extract Labs’ guarantee of the Loan.
The foregoing description of the Purchase Agreement and the transactions contemplated thereby does not purport to be complete, and is qualified in its entirety by reference to the complete text of such Purchase Agreement, a copy of which will be filed as an exhibit to the Company’s next periodic report.
Item 3.02 Unregistered Sales of Equity Securities
The information set forth in Item 1.01 of this Current Report on Form 8-K (this “Current Report”) regarding the issuance of the Closing Shares and the Earnout Amount is incorporated by reference into this Item 3.02.
The issuance of the shares of the Company’s common stock in connection with the Acquisition is exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on exemptions from the registration requirements of the Securities Act in transactions not involved in a public offering pursuant to Section 4(a)(2) and/or Regulation D of the Securities Act.
Item 7.01 Regulation FD Disclosure
On November 21, 2024, the Company issued a press release announcing the Acquisition. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information set forth under Item 7.01 of this Current Report on Form 8-K (“Current Report”), including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
Wolfman Jack Said;
Wolf-man jack
1 week ago
WQLF SAYS: Extract Labs AcQuisition
https://www.extractlabs.com/
CV SCIENCES, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE EXTRACT LABS
SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced that it has entered into a definitive agreement (the "Purchase Agreement") to acquire Extract Labs, Inc. ("Extract Labs"), a leading manufacturer and distributor of premium cannabinoid products including gummies, topicals and tinctures. Extract Labs branded products are sold through a range of sales channels from B2B to B2C. Extract Labs has operational flexibility allowing low to large minimum order quantity ("MOQ") production runs, allowing for efficient use of capital and the ability to increase speed to market for new product development. Extract Labs is GMP-certified and FDA-registered. The acquisition is expected to create the opportunity to increase our sales to current and new clients. In addition, we intend to in-source production of certain of our key products.
CV Sciences (PRNewsfoto/CV Sciences, Inc.)
"We are thrilled that Extract Labs and its employees are joining CV Sciences as another milestone in our transition to a thriving health and wellness company. The acquisition synergies are expected to increase our revenue and customer base, allow us to leverage our key assets, optimize operations and processes, and drive long-term growth and shareholder value. Extract Labs is a stand-alone profitable business and our plan is to increase its existing revenue base and further leverage its existing capacity," said Joseph Dowling, Chief Executive Officer of CV Sciences. "In addition, we are planning to in-source the manufacturing of select +PlusCBD™ branded products providing an opportunity for meaningful cost savings. Extract Labs manufacturing capability will provide us with greater control over our supply chain and accelerate our new product development cycle."
The total consideration for the acquisition of Extract Labs payable at closing, consists of (i) a cash payment of $400,000 (the "Closing Payment"), less the amount of certain holdbacks and adjustments, and (ii) the issuance of shares of CV Sciences' common stock valued at $1,000,000 based on the sixty day volume weighted average price ("VWAP") of CV Sciences' common stock.
In addition to the consideration payable at closing, and as further consideration for the acquisition, the Extract Labs sellers will be eligible to receive up to $600,000 of additional shares of CV Sciences' common stock if Extract Labs satisfies certain revenue targets during the two 12-month periods following the closing date. Such shares will be issued based on the thirty day VWAP of CV Sciences' common stock as of the end of each such 12-month period and will be calculated as follows:
If Extract Labs' Net Revenue is at least $4,600,000 in the relevant calculation period, then the Extract Labs Earnout Amount for such period will be $300,000. If Extract Labs' Net Revenue is at least $4,300,000 but less than $4,600,000 in the relevant calculation period, then the Extract Labs Earnout Amount for such period will be $200,000. If Extract Labs' Net Revenue is at least $4,000,000 but less than $4,300,000 in the relevant calculation period, then the Extract Labs Earnout Amount for such period will be $100,000. If Extract Labs' Net Revenue is at least $3,500,000 but less than $4,000,000 in the relevant calculation period, then the Extract Labs Earnout Amount for such period will be $50,000. If Extract Labs' Net Revenue is less than $3,500,000 in the relevant calculation period, then the Extract Labs Earnout Amount for such period will be $0.
The acquisition is expected to close during the first quarter of 2025. Closing of the transaction is subject to customary conditions precedent. On November 21, 2024, CV Sciences, Inc. filed a Current Report on Form 8-K which includes a description of the material terms of the transaction. Investors are encouraged to read such filing in its entirety.
https://ir.cvsciences.com/press-releases/detail/231/cv-sciences-inc-enters-into-definitive-agreement-to
One Man's Vision
From the battlefields of Iraq to the forefront of hemp innovation, Craig Henderson’s journey is nothing short of extraordinary. After witnessing the therapeutic benefits of hemp among his fellow veterans, Craig was inspired to make a difference. With just basic equipment and a big dream, he began extracting hemp in his garage—planting the seeds of what would become Extract Labs. His passion for quality and helping others has turned a humble garage project into an industry leader.
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
Thomas@yahoo
14 hours ago
Zorax
3 days ago
ap17
6 days ago
